Skip to main content

A. Bourla

Equibles does not estimate personal net worth.

Get an email with a short summary when Pfizer Inc publishes a filing, an earnings call transcript or a press release.

Get PFE alerts

About A. Bourla

A. Bourla is recorded as CEO at Pfizer Inc (PFE). The proxy statement of Pfizer Inc reports total compensation of $27,585,301 for A. Bourla in fiscal 2025, including a base salary of $1,800,000. Disclosed compensation is on record for 9 fiscal years. Pfizer Inc is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Pfizer Inc includes I. Read (Chairman), Cecile Guegan (CFO), D. Denton (CFO) and 6 others.

Affiliation history

Company network

Current role

Drug Manufacturers - General · Healthcare

CEO

Leadership on record at Pfizer Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Pfizer Inc (PFE) $1,800,000 $27,585,301
2024 Pfizer Inc (PFE) $1,800,000 $24,648,727
2023 Pfizer Inc (PFE) $1,787,500 $21,562,064
2022 Pfizer Inc (PFE) $1,737,500 $33,017,453
2021 Pfizer Inc (PFE) $1,687,500 $24,353,219
2020 Pfizer Inc (PFE) $1,650,000 $21,033,570
2019 Pfizer Inc (PFE) $1,600,000 $17,928,963
2018 Pfizer Inc (PFE) $1,400,000 $9,854,557
2017 Pfizer Inc (PFE) $1,170,000 $8,836,301

Recent activity

No call appearances or filed executive changes recorded yet.